| Market Cap | 51Cr 45Cr 42Cr 39Cr 73Cr 4.84TCr 74Cr 499.12Cr 193.27Cr 2.39TCr 192.72Cr 188.49Cr 8.3TCr | P/E 2017 |
-17.4x | P/E 2018 | -41.8x |
|---|---|---|---|---|---|
| Enterprise Value | 46Cr 40Cr 37Cr 35Cr 65Cr 4.34TCr 67Cr 447.5Cr 173.28Cr 2.14TCr 172.79Cr 169Cr 7.44TCr | EV / Sales 2017 |
5,39,19,197x | EV / Sales 2018 | 1,94,87,976x |
| Free-Float |
80.58% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -8.86% | - | - | 35Cr | |
| -0.32% | -2.95% | -15.86% | -10.22% | 1.24TCr | |
| -2.14% | -4.72% | -38.88% | -58.74% | 461.73Cr | |
| -0.57% | -4.82% | -16.82% | -7.88% | 413.33Cr | |
| -3.74% | -2.40% | +3.53% | -42.82% | 374.41Cr | |
| -3.92% | -6.18% | +7.09% | -20.51% | 370.76Cr | |
| -1.01% | -1.97% | -8.83% | -10.15% | 348Cr | |
| -2.50% | -6.03% | -15.72% | -6.23% | 298.53Cr | |
| -4.14% | -5.96% | -11.73% | -28.79% | 232.61Cr | |
| 0.00% | -3.73% | -15.23% | +27.43% | 160.51Cr | |
| Average | -1.83% | -3.70% | -12.49% | -17.55% | 433.09Cr | |
| Weighted average by Cap. | -1.66% | -3.70% | -13.73% | -19.08% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 3.08 2.7 2.49 2.33 4.37 290.25 4.46 29.93 11.59 143.27 11.56 11.3 497.8 | 18.69 16.42 15.13 14.17 26.53 1.76T 27.1 181.8 70.4 870.09 70.2 68.66 3.02T |
| Net income | -88.91L -78.12L -71.98L -67.39L -1.26Cr -84Cr -1.29Cr -8.65Cr -3.35Cr -41Cr -3.34Cr -3.27Cr -143.8Cr | -84.14L -73.92L -68.11L -63.77L -1.19Cr -79Cr -1.22Cr -8.18Cr -3.17Cr -39Cr -3.16Cr -3.09Cr -136.08Cr |
| Net Debt | -18.39L -16.16L -14.89L -13.94L -26.09L -17Cr -26.66L -1.79Cr -69.25L -8.56Cr -69.05L -67.54L -30Cr | -5.31Cr -4.66Cr -4.3Cr -4.02Cr -7.53Cr -500.51Cr -7.7Cr -52Cr -20Cr -247.05Cr -20Cr -19Cr -858.41Cr |
Employees
-
Sector
Pharmaceuticals
